Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents…
The post New patent expiration for Genentech Inc drug ESBRIET appeared …
New patent expiration for Genentech Inc drug ESBRIET Read Post »
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-one…
The post New patent expiration for Teva Pharm drug AIRDUO RE…
New patent expiration for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Annual Drug Patent Expirations for DIOVAN Diovan is a drug marketed by Novartis and is included in three NDAs. It is available from ten suppliers. There are two patents protecting…
The post New patent expiration for Novartis drug DIOVAN appeared …
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…
The post New patent expiration for Teva Pharm drug ARMONAIR R…
New patent expiration for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for DIOVAN+HCT Diovan Hct is a drug marketed by Novartis and is included in one NDA. It is available from nine suppliers. There is one patent…
The post New patent expiration for Novartis drug DIOVAN HCT appeared fir…
New patent expiration for Novartis drug DIOVAN HCT Read Post »
Annual Drug Patent Expirations for EXFORGE Exforge is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There are four patents protecting…
The post New patent expiration for Novartis drug EXFORGE appea…
Annual Drug Patent Expirations for EXFORGE+HCT Exforge Hct is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Novartis drug EXFORGE HCT appeared first …
New patent expiration for Novartis drug EXFORGE HCT Read Post »
QVAR 80 (beclomethasone dipropionate) Teva branded pharm Patent: 6,446,627 Expiration: Dec 18, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent …
Drug Patent Expirations for the Week of December 17, 2017 Read Post »
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Teva Branded drug PROAIR RESPI…
New patent expiration for Teva Branded drug PROAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. There are four patents protecting this drug. This drug…
The post New patent expiration for Norton Waterford drug Q…
New patent expiration for Norton Waterford drug QVAR REDIHALER Read Post »